Compare LIDR & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIDR | XTNT |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | 45 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.8M | 68.9M |
| IPO Year | N/A | 2009 |
| Metric | LIDR | XTNT |
|---|---|---|
| Price | $1.82 | $0.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $4.75 | $1.00 |
| AVG Volume (30 Days) | ★ 6.0M | 118.1K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $53,337,000.00 |
| Revenue This Year | $2,604.29 | N/A |
| Revenue Next Year | $466.58 | $9.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.68 | $0.44 |
| 52 Week High | $6.44 | $0.95 |
| Indicator | LIDR | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 36.82 |
| Support Level | $1.80 | $0.44 |
| Resistance Level | $2.75 | $0.68 |
| Average True Range (ATR) | 0.15 | 0.03 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 8.08 | 16.47 |
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.